Webinar: Peptide Receptor Radiotherapy for Neuroendocrine Tumors
10/20/2015 | null - null
Learn more about Peptide Receptor Radionuclide Therapy (PRRT), how it works, where it is being used, and who is eligible for this treatment. Join Josh Mailman, President of NorCal CarciNET; Dr. Edward M. Wolin, Director of Neuroendocrine and GI Oncology and Director of Clinicial Research at the University of Kentucky; and Dr. Erik Mittra, Clinical Assistant Professor, Department of Radiology & Nuclear Medicine at Stanford University in California, on Tuesday, October 20 at 12:00 pm, Eastern Time, for a free webinar. This webinar is sponsored by NorCal CarciNET and the Society of Nuclear Medicine and Molecular Imaging. Click here for the webinar flyer and click here to register.